ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

GSK Gsk Plc

1,775.00
-8.50 (-0.48%)
17 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -8.50 -0.48% 1,775.00 1,771.00 1,771.50 1,779.00 1,764.50 1,773.50 9,685,415 16:35:19
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 14.80 72.91B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,783.50p. Over the last year, Gsk shares have traded in a share price range of 1,302.60p to 1,820.00p.

Gsk currently has 4,117,033,438 shares in issue. The market capitalisation of Gsk is £72.91 billion. Gsk has a price to earnings ratio (PE ratio) of 14.80.

Gsk Share Discussion Threads

Showing 10876 to 10900 of 33175 messages
Chat Pages: Latest  439  438  437  436  435  434  433  432  431  430  429  428  Older
DateSubjectAuthorDiscuss
09/6/2015
10:43
You have to allow for the UKX level as well, we have come off over 200 now.
GSK is off more than double that on a % basis.

essentialinvestor
09/6/2015
10:32
Reinvest the div and wait. Only strategy.
blueledge2
09/6/2015
10:07
Witty will not go down without a fight, 30 years with GSK,
it would be a humiliating way to end his career imv as this is his strategy.
I would expect every single measure to extract value being considered
over the next 12 months, with deeper cost costs than previous guidance as one option.

essentialinvestor
09/6/2015
10:00
Ultimate breakup more likely Michael if growth is not re-established.

New CEO, strategic review .. ?

How much would the OTC business be worth to RB. alone, as one example,
GSK have an option to buy Novartis out of their minority stake.

essentialinvestor
09/6/2015
09:58
Never mind - a bid coming at this rate ...... ;0)
tradermichael
09/6/2015
09:57
Depends on your timeframe blue, but you are getting a fat income stream
(at least for now) while you wait.

essentialinvestor
09/6/2015
09:54
I am just frustrated having brought at the wrong time.
blueledge2
09/6/2015
09:50
Well if this rate of decline continued by November GSK would be worthless,
so no it is very unlikely to go down every day ).

essentialinvestor
09/6/2015
09:32
Down again. Predictable. Cant go down every day?
blueledge2
09/6/2015
08:53
Video interview with the CEO on the FT site, agree with a lot of what
Witty says, he makes some valid points, worth a watch.

He has about 12 months to restart growth IMV.

essentialinvestor
08/6/2015
15:54
I've just read.
essentialinvestor
08/6/2015
15:47
Now they have a problem with noodles. You could not make it up|
blueledge2
08/6/2015
15:30
Seems to be down every day.
blueledge2
08/6/2015
13:11
Few would disagree, just about where you see the valuation.

Now in correction territory here, more than 10% from the high.

essentialinvestor
08/6/2015
11:25
Still think this is a great company. I'm adding into weakness :0).

This seems minor

DYOR, DONT FOLLOW ME :0)

solooiler
08/6/2015
10:38
Mine is a metered does, it counts down on each use.

Easy to carry around as it's much smaller than my blue inhaler.

essentialinvestor
08/6/2015
10:36
It is important to note, though Advair/Seretide had gone off US patent in end 2010, the patent protection for the “Diskus” device that dispenses the powder version of the fixed dose drugs combination, continues till 2016. For the inhaler device that dispenses the aerosol version of the same drugs, the patent remains valid until 2025.
tradermichael
08/6/2015
10:23
Me too,does that mean that the health service will stop using Glaxo's,or do they reduce the price?

Brilliant stuff I find.

2hoggy
08/6/2015
09:32
Seretide generic launch in the UK announced,
might be the generic version on my next prescription as I use it.

essentialinvestor
08/6/2015
09:23
Only one month for the divi payout. 19p/share will enable me to buy loads more ..... 0)
tradermichael
08/6/2015
08:42
The sun will come out tomorrow eh Michael?.

Its Always a day away with GSK.

essentialinvestor
08/6/2015
08:03
Not another down day surely?
blueledge2
07/6/2015
17:59
Plenty new potential here:
tradermichael
06/6/2015
12:07
Spread Betting and CFDs June Magazine edition now online at This month's premium features includes: How to Pick the Perfect Share - the Seven Secrets to Success - Searching for Quality Companies - Robbie Burns' Trading Diary - Mellon on the Markets - Currency Corner - Fund Manager: Emmanuel Lemelson - Why I'm a Long-Term US Dollar Bull and much more...
shar65
06/6/2015
11:57
hxxp://www.barchart.com/opinions/stocks/GSK.LS

check this out might be further to fall

mj19
Chat Pages: Latest  439  438  437  436  435  434  433  432  431  430  429  428  Older